Page last updated: 2024-11-04

scriptaid and Head and Neck Neoplasms

scriptaid has been researched along with Head and Neck Neoplasms in 1 studies

scriptide: provokes translocation of GLUT4 to increase glucose uptake; structure in first source

Head and Neck Neoplasms: Soft tissue tumors or cancer arising from the mucosal surfaces of the LIP; oral cavity; PHARYNX; LARYNX; and cervical esophagus. Other sites included are the NOSE and PARANASAL SINUSES; SALIVARY GLANDS; THYROID GLAND and PARATHYROID GLANDS; and MELANOMA and non-melanoma skin cancers of the head and neck. (from Holland et al., Cancer Medicine, 4th ed, p1651)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kuribayashi, T1
Ohara, M1
Sora, S1
Kubota, N1

Other Studies

1 other study available for scriptaid and Head and Neck Neoplasms

ArticleYear
Scriptaid, a novel histone deacetylase inhibitor, enhances the response of human tumor cells to radiation.
    International journal of molecular medicine, 2010, Volume: 25, Issue:1

    Topics: Antigens, Nuclear; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Survival; DNA Breaks, Double-Str

2010